| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19959579
[patent_doc_number] => RE050459
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-06-17
[patent_title] => Ultra high molecular weight polyethylene multifilament yarn
[patent_app_type] => reissue
[patent_app_number] => 18/087665
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 853
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087665
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/087665 | Ultra high molecular weight polyethylene multifilament yarn | Dec 21, 2022 | Issued |
Array
(
[id] => 19171375
[patent_doc_number] => 20240157349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => PALLADIUM PRECATALYST FOR CROSS-COUPLING REACTION AND SYNTHESIS METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/080861
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080861 | Palladium precatalyst for cross-coupling reaction and synthesis method thereof | Dec 13, 2022 | Issued |
Array
(
[id] => 19767601
[patent_doc_number] => 20250049027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => PLANT PATHOGEN COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/719781
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719781
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719781 | PLANT PATHOGEN COMPOSITION | Dec 13, 2022 | Pending |
Array
(
[id] => 19752684
[patent_doc_number] => 20250041249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => METHOD OF TREATING LIVER STEATOSIS WITH BIOAVAILABLE FORMULATION OF OLEOYLETHANOLAMIDE
[patent_app_type] => utility
[patent_app_number] => 18/719687
[patent_app_country] => US
[patent_app_date] => 2022-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719687 | METHOD OF TREATING LIVER STEATOSIS WITH BIOAVAILABLE FORMULATION OF OLEOYLETHANOLAMIDE | Dec 11, 2022 | Pending |
Array
(
[id] => 19744073
[patent_doc_number] => 20250032638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => Novel Cancer Treatments with TLR7/8 Agonists
[patent_app_type] => utility
[patent_app_number] => 18/716482
[patent_app_country] => US
[patent_app_date] => 2022-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18716482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/716482 | Novel Cancer Treatments with TLR7/8 Agonists | Dec 11, 2022 | Pending |
| 18/070855 | ULTRA-THIN FABRIC, DEVICES, AND METHODS | Nov 28, 2022 | Pending |
Array
(
[id] => 19274370
[patent_doc_number] => 12024480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Polynitroso compound, its preparation and electrochemical use
[patent_app_type] => utility
[patent_app_number] => 18/059516
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 52
[patent_no_of_words] => 12737
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059516
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059516 | Polynitroso compound, its preparation and electrochemical use | Nov 28, 2022 | Issued |
Array
(
[id] => 19768350
[patent_doc_number] => 20250049776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/711529
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18711529
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/711529 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS | Nov 16, 2022 | Pending |
| 18/056447 | HIGH PROTEIN DENATURED WHEY PROTEIN COMPOSITION, RELATED PRODUCTS, METHOD OF PRODUCTION AND USES THEREOF | Nov 16, 2022 | Abandoned |
Array
(
[id] => 19012995
[patent_doc_number] => 11919910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Spiropyrrolidine derived antiviral agents
[patent_app_type] => utility
[patent_app_number] => 17/983474
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12814
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983474 | Spiropyrrolidine derived antiviral agents | Nov 8, 2022 | Issued |
Array
(
[id] => 18375938
[patent_doc_number] => 20230151019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/983501
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 375
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983501 | Spiropyrrolidine derived antiviral agents | Nov 8, 2022 | Issued |
Array
(
[id] => 18626767
[patent_doc_number] => 20230285574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/974258
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17974258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/974258 | CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS | Oct 25, 2022 | Abandoned |
Array
(
[id] => 18362347
[patent_doc_number] => 20230143938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PYRAZOLOQUINOLINE KRAS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/937106
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937106 | Pyrazoloquinoline KRAS inhibitors | Sep 29, 2022 | Issued |
Array
(
[id] => 18267647
[patent_doc_number] => 20230088889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => BINUCLEAR IRON-FUSED PORPHYRIN
[patent_app_type] => utility
[patent_app_number] => 17/944783
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/944783 | Binuclear iron-fused porphyrin | Sep 13, 2022 | Issued |
Array
(
[id] => 18346707
[patent_doc_number] => 20230134817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/931843
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931843 | Bi-functional compounds and methods for targeted ubiquitination of androgen receptor | Sep 12, 2022 | Issued |
Array
(
[id] => 20533750
[patent_doc_number] => RE050800
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2026-02-17
[patent_title] => Pro-fragrance compounds
[patent_app_type] => reissue
[patent_app_number] => 17/903659
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1279
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17903659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/903659 | Pro-fragrance compounds | Sep 5, 2022 | Issued |
| 17/902539 | OXYGEN LINKED PYRIMIDINE DERIVATIVES | Sep 1, 2022 | Pending |
Array
(
[id] => 20300505
[patent_doc_number] => RE050642
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-10-21
[patent_title] => Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
[patent_app_type] => reissue
[patent_app_number] => 17/896658
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2868
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/896658 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Aug 25, 2022 | Issued |
| 17/822611 | METHOD OF TREATMENT WITH TRADIPITANT | Aug 25, 2022 | Abandoned |
Array
(
[id] => 18224649
[patent_doc_number] => 20230063643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
[patent_app_type] => utility
[patent_app_number] => 17/885475
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885475 | JAK inhibitors containing a 4-membered heterocyclic amide | Aug 9, 2022 | Issued |